Bayer to assume Aleve marketing by year-end under Roche joint venture.

BAYER TO ASSUME ALEVE MARKETING BY END OF 1996 under a 50/50 joint venture agreement with Roche announced by the companies on Sept. 16. Bayer's Morris Township, N.J.-based Consumer Care Division will handle U.S. sales and marketing of the joint venture brands, which also include Roche's Femstat 3 vaginal yeast infection treatment and four Bayer brands: Actron and Vanquish analgesics; Midol menstrual discomfort products; and Mycelex-7 yeast infection treatment.